Association of Thyrotropin Suppression With Survival Outcomes in Patients With Intermediate- and High-Risk Differentiated Thyroid Cancer

IMPORTANCE: Suppression of thyrotropin (often referred to as thyroid-stimulating hormone, or TSH) with levothyroxine used in management of intermediate- and high-risk differentiated thyroid cancer (DTC) to reduce the likelihood of progression and death is based on conflicting evidence. OBJECTIVE: To...

Descripción completa

Detalles Bibliográficos
Autores principales: Klubo-Gwiezdzinska, Joanna, Auh, Sungyoung, Gershengorn, Marvin, Daley, Brianna, Bikas, Athanasios, Burman, Kenneth, Wartofsky, Leonard, Urken, Mark, Dewey, Eliza, Smallridge, Robert, Chindris, Ana-Maria, Kebebew, Electron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484595/
https://www.ncbi.nlm.nih.gov/pubmed/30707227
http://dx.doi.org/10.1001/jamanetworkopen.2018.7754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484595/
https://www.ncbi.nlm.nih.gov/pubmed/30707227
http://dx.doi.org/10.1001/jamanetworkopen.2018.7754

Ejemplares similares